SCHEDULE: FMR LLC Discloses Stake in QuidelOrtho Corp

FMR LLC, through its subsidiaries, has reported a beneficial ownership of 11.5% of QuidelOrtho Corp's common stock as of April 30, 2026.

Summary

• FMR LLC and its affiliates, including Abigail P. Johnson, have filed a Schedule 13G indicating beneficial ownership of QuidelOrtho Corp common stock.
• The filing, dated April 30, 2026, shows a total of 7,852,321.81 shares owned, representing 11.5% of the class.
• FMR LLC holds sole voting power for 7,850,418 shares and sole dispositive power for 7,852,321.81 shares.
• Abigail P. Johnson, as CEO of FMR LLC, is noted as a significant owner, with the Johnson family potentially forming a controlling group over FMR LLC.
• The filing clarifies that these securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral; it's a standard disclosure of ownership by a large investment firm and does not inherently signal positive or negative performance for QuidelOrtho Corp.

Positives

• FMR LLC, a significant investment management entity, has publicly disclosed its substantial stake in QuidelOrtho Corp, providing transparency to the market.
• The ownership stake of 11.5% indicates a considerable investment, potentially signaling confidence in QuidelOrtho Corp's long-term prospects from a major institutional investor.

Risks

• While not explicitly stated as a risk in this filing, a large institutional ownership can sometimes lead to increased volatility if the institution decides to divest its position.
• The filing mentions that members of the Johnson family may be deemed to form a controlling group with respect to FMR LLC, which could raise governance considerations for QuidelOrtho Corp if FMR LLC's influence becomes significant.

Future Outlook

This filing does not contain forward-looking statements or guidance from QuidelOrtho Corp. It solely reports on the beneficial ownership of securities by FMR LLC.

Management Comments

• "This filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies (collectively, the 'FMR Reporters')."
• "No one other person's interest in the COMMON STOCK of QUIDELORTHO CORP is more than five percent of the total outstanding COMMON STOCK."
• "Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating significant stakes in public companies. FMR LLC's filing indicates a substantial investment in the healthcare sector, specifically within the diagnostics and medical devices space where QuidelOrtho Corp operates.

Stakeholder Impact

• Shareholders: Increased transparency regarding a significant institutional investor's stake, potentially influencing market perception and trading activity.
• Management of QuidelOrtho Corp: Awareness of FMR LLC's substantial ownership and potential influence.
• FMR LLC Clients: Their investments are managed by FMR LLC, which holds this stake on their behalf.

Next Steps

• FMR LLC will continue to hold or manage its investment in QuidelOrtho Corp's common stock.
• QuidelOrtho Corp will continue its business operations as disclosed in its other SEC filings.

Key Dates

Keywords

QuidelOrtho Corp, FMR LLC, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Abigail P. Johnson, Investment Management, SEC Filing